Etoricoxib – 15 years in Russia: the main results in the treatment of rheumatic diseases
Background. According to epidemiological studies, chronic musculoskeletal pain affects more than 30% of people worldwide, causing a huge personal and social burden. Nonsteroidal anti-inflammatory drugs are widely used to treat musculoskeletal pain. The drug etoricoxib, highly selective for COX-2, is...
Furkejuvvon:
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Russo |
| Almmustuhtton: |
Open Systems Publication
2024-01-01
|
| Ráidu: | Лечащий Врач |
| Fáttát: | |
| Liŋkkat: | https://journal.lvrach.ru/jour/article/view/1179 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|